Vaccine hesitancy risks a 2023 tripledemic
This is the first year that patients can get vaccines to protect themselves against COVID, the flu, and RSV (respiratory syncytial virus), but a […]
Vaccine hesitancy risks a 2023 tripledemic Read More »
This is the first year that patients can get vaccines to protect themselves against COVID, the flu, and RSV (respiratory syncytial virus), but a […]
Vaccine hesitancy risks a 2023 tripledemic Read More »
Jennifer Camel-Toueg’s son was not getting better. “Alex, who is now 20 years old, was diagnosed with ulcerative colitis at 17,” recalled Camel-Toueg. “With
TrueTrials simplifies finding FDA-authorized cell therapy clinical trials Read More »
On September 22, the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) voted 11-1 to recommend one dose of
More good news for pediatric RSV immunizations Read More »
“The biotech sisterhood is the antidote to the pharma bros,” said Angie You, Ph.D., Chief Executive Officer at Architect Therapeutics, during a lively conversation
Meet the biotech sisterhood—women supporting women in the pharma sector Read More »
We need to make progress against the next pandemic, Phyllis Arthur, Senior Vice President of Infectious Diseases & Emerging Science Policy at the Biotechnology
Plan now for next pandemic, BIO’s Phyllis Arthur tells UN preparedness panel Read More »
The BIO Investor Forum 2023, hosted by the Biotechnology Innovation Organization (BIO), is right around the corner. Returning to San Francisco on October 17-18,
Why attend the BIO Investor Forum 2023? An investor and a company explain. Read More »
People six months and older should have one of the updated COVID-19 vaccines released by Pfizer-BioNTech and Moderna, under the recommendation approved Sept. 12
CDC recommends everyone get the updated COVID-19 vaccines Read More »
Kintara Therapeutics, Biotechnology Innovation Organization (BIO) member, is an innovative, patient-centered biotech company that is working to change the game when it comes to
Kintara Q&A: novel treatments for aggressive cancers Read More »
September is a perfect time to schedule your flu vaccine– as well as COVID and, if you’re eligible, the new RSV vaccines. And with
What you need to know about the upcoming flu season Read More »
The U.S. Food and Drug Administration (FDA) approved Pfizer’s respiratory syncytial virus vaccine, Abrysvo, to prevent RSV in infants. The August 21 decision comes
FDA approves first vaccine to prevent RSV in infants Read More »